Literature DB >> 11710643

Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines.

E M Bindels1, M Vermey, N J De Both, T H van der Kwast.   

Abstract

To investigate the importance of the microenvironment in bladder cancer invasion, a panel of six bladder carcinoma cell lines (SD, RT112, JON, 1207, T24, and J82) was tested in both in vitro and in vivo invasion assays. Furthermore, invasiveness was correlated with the expression of components of the E-cadherin-catenin complex. The E-cadherin-negative cell lines, T24 and J82, displayed a high in vitro invasive capacity, whereas the E-cadherin-positive cell lines, SD and JON, completely lacked in vitro invasive capacity. In contrast, in vivo invasion was noted for all cell lines, with the exception of cell line JON. Most notably, SD formed highly invasive tumors in vivo. The in vivo invasiveness of the E-cadherin-positive bladder carcinoma cell lines was associated with a heterogeneous expression of the E-cadherin-catenin complex. The discrepancy between in vitro and in vivo invasive behavior implies that, in vivo, the microenvironment plays an important role in the establishment of the invasive phenotype. In addition, it was found that orthotopic xenografting of 1207 and T24 bladder carcinoma cells resulted in site-specific tumor take and an enhanced tumor outgrowth and invasiveness, respectively, compared with heterotopic (i.e., subcutaneous) inoculation. We conclude that the site-specific growth and invasion of the bladder carcinoma cell lines in vivo and the observed assay specific invasion (in vitro vs in vivo) points to an effect of the local (bladder) microenvironment on tumor cell behavior.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710643     DOI: 10.1007/s004280100419

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  7 in total

1.  Impact of 4HPR on the expression of E-Cad in human bladder transitional epithelial cancer cells T24.

Authors:  Eyou Wang; Jun Li; Guohua Yang; Shan Zhong; Tongzu Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

2.  Different subtypes of carcinoma in situ of the bladder do not have a different prognosis.

Authors:  Eva Compérat; Solene-Florence Jacquet; Justine Varinot; Pierre Conort; Morgan Roupret; Emmanuel Chartier-Kastler; Marc-Olivier Bitker; Johannes Alfred Witjes; Olivier Cussenot
Journal:  Virchows Arch       Date:  2013-02-10       Impact factor: 4.064

3.  Extracellular matrix alterations in conventional renal cell carcinomas by tissue microarray profiling influenced by the persistent, long-term, low-dose ionizing radiation exposure in humans.

Authors:  Alina Romanenko; Luisa Morell-Quadreny; David Ramos; Valentin Nepomnyaschiy; Alexander Vozianov; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2006-03-09       Impact factor: 4.064

Review 4.  [Bladder carcinoma cell lines as models of the pathobiology of bladder cancer. Review of the literature and establishment of a new progression series].

Authors:  J Hatina; W Huckenbeck; H Rieder; H-H Seifert; W A Schulz
Journal:  Urologe A       Date:  2008-06       Impact factor: 0.639

5.  Experimental rat bladder urothelial cell carcinoma models.

Authors:  Harm C Arentsen; Kees Hendricksen; Egbert Oosterwijk; J Alfred Witjes
Journal:  World J Urol       Date:  2009-02-15       Impact factor: 4.226

6.  Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway.

Authors:  Cong Zhang; Xiangping Chang; Dongshan Chen; Feilong Yang; Zeyan Li; Dawei Li; Nengwang Yu; Lei Yan; Hainan Liu; Zhonghua Xu
Journal:  Cancer Manag Res       Date:  2019-08-22       Impact factor: 3.989

7.  Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals.

Authors:  Qun Rao; Yuan Chen; Chiuan-Ren Yeh; Jie Ding; Lei Li; Chawnshang Chang; Shuyuan Yeh
Journal:  Oncotarget       Date:  2016-02-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.